Investigation of Statin Medication Use in Elderly Patients with Cardiovascular Disease on Regular Physical Examination and the Relationship with Glucolipid Metabolism and Adverse Cardiovascular Prognosis
Table 1
Analysis of statin use in elderly patients with cardiovascular disease.
Item
60-69 years ()
70-79 years ()
≥80 years ()
Type of drug
Atorvastatin calcium
330 (41.51)
260 (40.82)
285 (41.36)
Rosuvastatin calcium
322 (40.50)
254 (39.87)
276 (40.06)
Simvastatin
33 (4.15)
29 (4.55)
28 (4.06)
Fluvastatin
9 (1.13)
7 (1.10)
6 (0.87)
Pitavastatin
4 (0.5)
3 (0.47)
2 (0.29)
Drug intensity
Low-intensity statin
171 (21.51)
214 (33.59)
543 (78.81)
Moderate-intensity statin
525 (66.04)
337 (52.90)
54 (7.84)
High-intensity statin
2 (0.25)
2 (0.31)
0 (0.00)
Total
698 (87.80)
553 (86.81)
597 (86.65)
Note: Comparison of statin intensity among the three groups, .
